Stock 4887 SAWAI GROUP HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sawai Group Holdings Co., Ltd.

Equities

4887

JP3323040000

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 07:00:00 27/06/2024 BST 		5-day change 1st Jan Change
6,379 JPY +0.24% Intraday chart for Sawai Group Holdings Co., Ltd. +12.56% +22.46%
06-26 Sawai Group Plans 33 Billion Yen Share Buyback; Shares Up 8% MT
06-25 Sawai Group Holdings Co., Ltd. announces an Equity Buyback for 6,900,000 shares, representing 15.75% for ¥33,000 million. CI

Business Summary

Sawai Group Holdings Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of medical and over-the-counter drugs. The Company operates in two segments. The Japan segment is engaged in medical and healthcare-related businesses such as manufacture and sale of pharmaceuticals and medical devices, as well as various related businesses. The America segment is engaged in the sale of manufactured pharmaceutical products to wholesale stores in America. The company is also engaged in the research and development of pharmaceutical products.

Number of employees: 3,393

Sales per Business

JPY in Million2023Weight2024Weight Delta
Circulatory System Drugs
23.8 %
49,135 24.5 % 42,136 23.8 % -14.24%
Central Nervous System Drugs
13.9 %
42,147 21.0 % 24,570 13.9 % -41.70%
Digestive System Drugs
10.8 %
18,357 9.2 % 19,089 10.8 % +3.99%
Other Metabolic Drugs
10.3 %
15,827 7.9 % 18,145 10.3 % +14.65%
Blood and Body Fluid Drugs
9.1 %
16,448 8.2 % 16,010 9.1 % -2.66%
Other
5.8 %
19,520 9.7 % 10,279 5.8 % -47.34%
Antibiotics
5.2 %
8,033 4.0 % 9,269 5.2 % +15.39%
Vitamins
4.2 %
7,426 3.7 % 7,363 4.2 % -0.85%
Allergy Drugs
3.9 %
6,522 3.3 % 6,951 3.9 % +6.58%
Oncology Drugs
3.4 %
5,662 2.8 % 6,097 3.4 % +7.68%
Respiratory System Drugs
3.4 %
5,236 2.6 % 6,022 3.4 % +15.01%
Chemotherapy Drugs
3.2 %
- - 5,705 3.2 % -
Urinogenital and Anal Drugs
3.0 %
6,033 3.0 % 5,227 3.0 % -13.36%

Sales per region

JPY in Million2023Weight2024Weight Delta
Japan
100.0 %
163,702 81.7 % 176,862 100.0 % +8.04%

Managers

Managers TitleAgeSince
Mitsuo Sawai CEO
 Chief Executive Officer 67 31/03/21
Kazuhiko Sueyoshi PSD
 President 66 31/03/21
Toru Terashima BRD
 Director/Board Member 64 31/03/21
Kenzo Sawai BRD
 Director/Board Member 56 31/03/21
Tadao Tsubokura AUD
 Comptroller/Controller/Auditor 63 31/03/21
Taku Nakaoka PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Mitsuo Sawai CEO
 Chief Executive Officer 67 31/03/21
Kenzo Sawai BRD
 Director/Board Member 56 31/03/21
Masatoshi Ohara BRD
 Director/Board Member 73 31/03/21
Kazuhiko Sueyoshi PSD
 President 66 31/03/21
Nawomi Todo BRD
 Director/Board Member 64 31/03/21
Toru Terashima BRD
 Director/Board Member 64 31/03/21

Shareholders

NameEquities%Valuation
Silchester International Investors LLP
8.839 %
3,871,600 8.839 % 151 M ¥
Nomura Asset Management Co., Ltd.
6.554 %
2,870,900 6.554 % 112 M ¥
JPMorgan Asset Management (Japan) Ltd.
3.898 %
1,707,600 3.898 % 66 M ¥
JPMorgan Asset Management (Asia Pacific) Ltd.
2.954 %
1,293,800 2.954 % 50 M ¥
Mitsuo Sawai
2.413 %
1,057,000 2.413 % 41 M ¥
Sawai Hiroyuki Family
2.269 %
994,000 2.269 % 39 M ¥
Kenzo Sawai
1.950 %
854,000 1.950 % 33 M ¥
Nikko Asset Management Co., Ltd.
1.655 %
725,000 1.655 % 28 M ¥
SUMITOMO MITSUI FINANCIAL GROUP, INC.
1.484 %
650,000 1.484 % 25 M ¥
Sawai Mitsuo KK
1.472 %
645,000 1.472 % 25 M ¥

Holdings

NameEquities%Valuation
SUMITOMO CORPORATION
0.07%
 858,000 0.07% 22,281,960 $
NIPPON KAYAKU CO., LTD.
0.51%
 875,000 0.51% 7,113,251 $
MEDIPAL HOLDINGS CORPORATION
0.10%
 218,100 0.10% 3,208,803 $
ALFRESA HOLDINGS CORPORATION
0.11%
 224,000 0.11% 3,155,201 $
YAKULT HONSHA CO.,LTD.
0.04%
 148,800 0.04% 2,709,071 $
MEDICAL IKKOU GROUP CO.,LTD.
3.44%
 140,000 3.44% 2,280,697 $
DAITO PHARMACEUTICAL CO.,LTD.
0.62%
 96,800 0.62% 1,371,197 $
ASAHI PRINTING CO.,LTD.
0.71%
 165,200 0.71% 1,008,156 $
SUSMED,INC.
1.46%
 245,000 1.46% 829,425 $
TECHNO RYOWA LTD.
0.14%
 31,460 0.14% 364,359 $

Company contact information

SAWAI GROUP HOLDINGS Co., Ltd.

5-2-30 Miyahara Yodogawa-Ku

532-0003, Osaka

+

http://www.sawaigroup.holdings
address Sawai Group Holdings Co., Ltd.(4887)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Sawai Group Holdings Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
6,379 JPY
Average target price
6,928 JPY
Spread / Average Target
+8.60%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SAWAI GROUP HOLDINGS CO., LTD. Stock Sawai Group Holdings Co., Ltd.
+22.46% 1.73B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.95% 811B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.62% 640B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.98% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.08% 333B
ABBVIE INC. Stock AbbVie Inc.
+9.05% 302B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.30% 246B
ROCHE HOLDING AG Stock Roche Holding AG
+2.41% 225B
NOVARTIS AG Stock Novartis AG
+12.47% 218B
AMGEN INC. Stock Amgen Inc.
+8.91% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4887 Stock
  4. Company Sawai Group Holdings Co., Ltd.